| Net Cash Provided by (Used in) Operating Activities |
5.72M |
USD |
+312% |
Q3 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
-2.12M |
USD |
-334% |
Q3 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Investing Activities |
-243K |
USD |
+44.5% |
Q3 2025 |
Q1 2026 |
| Common Stock, Shares Authorized |
10M |
shares |
0% |
Q3 2025 |
Q1 2026 |
| Common Stock, Shares, Issued |
3.13M |
shares |
0% |
Q3 2025 |
Q1 2026 |
| Common Stock, Par or Stated Value Per Share |
0.33 |
USD/shares |
0% |
Q3 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
316K |
USD |
|
Q3 2023 |
Q1 2024 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
22.2M |
USD |
+362% |
Q3 2025 |
Q1 2026 |
| Deferred Tax Assets, Gross |
1.01M |
USD |
-76% |
Q3 2025 |
Q1 2026 |
| Depreciation |
118K |
USD |
+7.77% |
Q3 2025 |
Q1 2026 |
| Payments to Acquire Property, Plant, and Equipment |
1.29M |
USD |
+94.3% |
Q3 2025 |
Q1 2026 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
8.72M |
USD |
+37.6% |
Q3 2025 |
Q1 2026 |
| Property, Plant and Equipment, Gross |
18.2M |
USD |
+6.07% |
Q2 2025 |
FY 2025 |
| Deferred Income Tax Expense (Benefit) |
-108K |
USD |
-345% |
Q3 2025 |
Q1 2026 |
| Deferred Tax Assets, Net of Valuation Allowance |
888K |
USD |
|
Q1 2024 |
Q3 2024 |
| Share-based Payment Arrangement, Expense |
319K |
USD |
-3.12% |
Q3 2025 |
Q1 2026 |